{
    "Trade/Device Name(s)": [
        "ARIES\u00ae HSV 1&2 Assay"
    ],
    "Submitter Information": "Luminex Corporation",
    "510(k) Number": "K151906",
    "Predicate Device Reference 510(k) Number(s)": [
        "K151046"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PGI",
        "OOI"
    ],
    "Summary Letter Date": "July 10, 2015",
    "Summary Letter Received Date": "July 13, 2015",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3309",
        "21 CFR 862.2570"
    ],
    "Regulation Name(s)": [
        "Herpes simplex virus nucleic acid amplification assay",
        "Multiplex Instrument System"
    ],
    "Analyte Class(es)": [
        "virology",
        "genetic molecular"
    ],
    "Analyte(s)": [
        "Herpes Simplex Virus 1 DNA",
        "Herpes Simplex Virus 2 DNA"
    ],
    "Specimen Type(s)": [
        "Cutaneous lesion swab",
        "Mucocutaneous lesion swab"
    ],
    "Specimen Container(s)": [
        "Copan Universal Transport Medium",
        "Becton Dickinson Universal Viral Transport Media",
        "Copan branded Universal Transport Medium for LabCorp",
        "Quest Viral Culture Media"
    ],
    "Instrument(s)/Platform(s)": [
        "ARIES\u00ae System"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time PCR",
        "Nucleic acid extraction",
        "Fluorescence-based detection"
    ],
    "Methodologies": [
        "PCR-based qualitative detection",
        "Nucleic acid amplification",
        "Differentiation of HSV 1 and 2"
    ],
    "Submission Type(s)": [
        "Assay",
        "Cassette Kit",
        "Protocol File Kit",
        "Instrument",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for Luminex ARIES HSV 1&2 Assay, a PCR-based qualitative test for direct detection and differentiation of HSV 1 and 2 DNA from lesion specimens using the ARIES System.",
    "Indications for Use Summary": "A real-time PCR-based qualitative in vitro diagnostic test for direct detection and differentiation of Herpes Simplex Virus 1 and 2 DNA in cutaneous or mucocutaneous lesion specimens from symptomatic patients, as an aid in diagnosis of HSV infection, for use on the ARIES System.",
    "fda_folder": "Microbiology"
}